ASML’s, Billion

ASML’s €45 Billion Forecast Pits Monopoly Pricing Power Against a New US Export Threat

Published on 07/23/2026 at 05:40 | Redaktion boerse-global.de

ASML raises 2026 revenue guidance to €43-45B, flexes monopoly pricing power, hits High-NA milestone with Intel, while US MATCH Act threatens China service business.

ASML Faces Record Demand, Pricing Power, and US MATCH Act Threat in 2026
ASML’s €45 Billion Forecast Pits Monopoly Pricing Power Against a New US Export Threat Illustration mit AI erstellt übermittelt durch boerse-global.de

The quiet Dutch town of Veldhoven has become the unlikely epicenter of a global tug-of-war. ASML, the lithography giant whose machines are indispensable for producing the world’s most advanced chips, finds itself navigating a paradox: record demand for its cutting-edge technology collides with the most aggressive US legislative threat yet to its China business. For investors, the question is no longer simply whether ASML can sell its machines, but how much it can charge for them — and where it will be allowed to deliver them.

A New Pricing Dynamic Emerges

The company’s most recent quarterly report, published on July 15, 2026, reshaped the investment narrative. Management raised its 2026 revenue guidance to between €43 billion and €45 billion, a figure that comfortably surpassed market expectations and effectively shelved fears of an imminent “AI winter” in the lithography segment. But the real story lies beneath the top line: ASML is flexing its monopoly muscle.

Reports from the latest earnings season indicate the company is moving toward “value-based pricing,” seeking a larger slice of the profits its machines enable. This is creating friction with its largest customer, Taiwan Semiconductor Manufacturing Co., particularly around the cost of Low-NA EUV systems scheduled for delivery through 2028. Chipmakers have historically resisted price increases, but they have little leverage here. ASML holds a de facto monopoly on EUV technology, and its current market capitalization of €584 billion — reflected in a share price of roughly €1,580 — capitalizes that pricing power, even though the stock remains about 10% below its June 30 record high.

The High-NA Milestone and Intel’s Bet

While pricing negotiations simmer, the technological frontier is advancing. ASML recently confirmed a critical milestone for its next-generation High-NA EUV systems: Intel Foundry has begun series production of its “Panther Lake” processors using the new machines. This is a pivotal validation of ASML’s roadmap. Each High-NA system costs approximately €380 million, and demonstrating their integration into a commercial production line proves that sub-two-nanometer chip manufacturing is both technically feasible and economically viable — for customers willing to pay the premium.

Should investors sell immediately? Or is it worth buying Asml?

To meet surging demand, ASML plans to expand its EUV production capacity by 30% in 2027, with a further expansion of the same magnitude under consideration for 2028. Memory-chip makers SK Hynix and Samsung are also driving strong demand, reinforcing the bull case that the AI infrastructure boom is a structural, not cyclical, tailwind.

The MATCH Act Looms

Yet the industrial momentum faces a formidable geopolitical headwind. In April 2026, US lawmakers introduced the “MATCH Act,” a bill that represents a significant escalation in export controls. Unlike previous restrictions that targeted sales of new machines, this legislation would prohibit ASML from servicing already-installed DUV immersion systems in China. That would directly threaten the company’s most stable and profitable revenue stream: maintenance and high-margin upgrades on its installed base.

The Dutch government is pushing back. Trade Minister Sjoerd Sjoerdsma has expressed “irritation” at Washington’s attempts to dictate Dutch export policy, and the foreign trade minister traveled to Washington in late June to lobby against the plan. The bill remains in the consultation phase, but the uncertainty is already weighing on sentiment. China is expected to account for roughly 20% of ASML’s group revenue in 2026, and analysts estimate that 15% to 20% of long-term revenue could be at risk if the MATCH Act passes in its current form.

A Stock Caught Between Two Forces

The share price, currently hovering around €1,582, has gained 71.5% since the start of the year, but remains 9.5% below its all-time high. The relative strength index stands at 52.1, signaling balanced sentiment as investors weigh unbroken AI demand against rising trade-policy risks. The stock is trading about 4% above its 50-day moving average of €1,519.28, a level that bulls view as a critical support line.

Asml at a turning point? This analysis reveals what investors need to know now.

The market’s focus has shifted perceptibly. The debate is no longer about whether ASML can sell its machines — it clearly can. The open questions are how much it can charge and where it can still deliver. A decisive break above €1,600 would signal that investors are prioritizing the High-NA production ramp over geopolitical noise. Conversely, if the MATCH Act moves closer to a formal vote, or if The Hague signals stricter licensing requirements for DUV maintenance, the stock could test the 100-day moving average at €1,365.31.

The Bigger Picture

ASML has transcended its role as a mere participant in the semiconductor industry. With a monopoly on the technology that enables the most advanced chips, the company has become the infrastructure upon which the AI era is being built. That position gives it extraordinary pricing power — but also makes it a prime target in the US-China technology war. The coming weeks, with official statements expected from both the Dutch foreign trade ministry and the US Commerce Department, will determine whether the bull case or the bear case prevails. For now, ASML sits at the intersection of industrial inevitability and political uncertainty, and the market is watching closely.

Ad

Asml Stock: New Analysis - 23 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0010273215 | ASML’S | boerse | 69844643 |